CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell Lymphoma
Stopped Lack of Funding
Conditions
- CD19 Positive
- Mantle Cell Lymphoma
- Recurrent Diffuse Large B-Cell Lymphoma
- Recurrent Follicular Lymphoma
- Refractory B-Cell Non-Hodgkin Lymphoma
- Refractory Diffuse Large B-Cell Lymphoma
- Refractory Follicular Lymphoma
Interventions
- PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation
- DRUG: Carmustine
- DRUG: Cytarabine
- DRUG: Etoposide
- BIOLOGICAL: Filgrastim
- DRUG: Melphalan
- BIOLOGICAL: Rituximab
- BIOLOGICAL: Umbilical Cord Blood-derived Natural Killer Cells
Sponsor
M.D. Anderson Cancer Center
Collaborators